Katherine Fuh, MD, PhD

Associate Professor and Joh A. Kerner Chair in Gynecologic Oncology, Department of Obstetrics and Gynecology
Director of Translational and Basic Research, Division of Gynecologic Oncology
University of California, San Francisco

Katherine Fuh, MD, PhD, is an Associate Professor and the Joh A. Kerner Chair in Gynecologic Oncology in the Department of Obstetrics and Gynecology at University of California, San Francisco. She is the Director of Translational and Basic Research for the Division of Gynecologic Oncology. She returned to UCSF in 2022 after 9 years on faculty at Washington University in St. Louis. She graduated from Johns Hopkins University and obtained her M.D. at Georgetown University School of Medicine. She then completed her residency in obstetrics and gynecology at Stanford University and then entered the combined Gynecologic Oncology fellowship program at University of California, San Francisco (UCSF) and Stanford. She is also a graduate of the ARTS (Advanced Residency Training at Stanford) program. During this time, she combined clinical fellowship with advanced research training to complete a PhD degree in Cancer Biology at Stanford University. She was also a NIH-supported Reproductive Scientist Development Program (RSDP) Scholar.

She serves on national committees for clinical trials and translational research including Translational Co-Chair for the Uterine Corpus Committee for the NRG Clinical Trials Group. She is the international PI for GOG-3059/ENGOT OV-66, which is a Phase 3, Randomized, Double-Blind, Placebo-Controlled/Paclitaxel Study in Combination with Batiraxcept, an AXL inhibitor, for Platinum-resistant, High-Grade Serous Ovarian, Fallopian-Tube, and Peritoneal Cancer. She is the principal investigator on multiple grants from various federal and foundation sources. She is committed to developing better treatments for women with gynecologic cancers.